UBS Group stock ends the day modestly higher at the close on the NYSE
Published on 09/21/2026 at 23:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UBS Group stock, representing the U.S.-listed shares of the Swiss banking group, closed at USD 50.69 on the NYSE on September 21, 2026, gaining 0.50 percent from the prior close. Compared with the broader S&P 500, which was little changed on the day, the stock delivered a slightly stronger performance in percentage terms.
September 21, 2026 in numbers
UBS Group AG (ISIN CH0244767585, NYSE: UBS) opened the regular U.S. session around USD 50.30, moved within a day range between roughly USD 50.20 and USD 51.10, and settled at USD 50.69, comfortably within its recent 52-week trading corridor in U.S. dollars. The shares ended the day modestly higher, contrasting with a more subdued tone in the large-cap U.S. equity benchmarks.
On its home market, UBS Group shares on the SIX Swiss Exchange finished the September 21, 2026 session around 1.4 percent higher at the official close, recorded shortly after 11:35 a.m. ET, while the SMI index was also reported in positive territory by Swiss market data providers. According to Ad-hoc-news, investor attention remained focused on Swiss capital requirements and their potential to trim earnings per share by up to 10 percent, with at least one analyst house maintaining a positive stance on the stock despite the regulatory headwinds.
After the bell and next session
In after-hours trading on September 21, 2026, UBS Group stock was last quoted near USD 50.95 on an electronic venue at around 6:02 p.m. ET, a level roughly 0.50 percent above the official NYSE close, while a later data snapshot showed extended-hours indications near USD 51.04 before 7:10 p.m. ET. These prints suggest continued, though moderate, demand for the shares after the regular session. As Swissquote highlighted in a morning note, UBS CEO Sergio Ermotti described a proposed capital compromise as manageable for the bank, reinforcing expectations that regulatory negotiations remain an important theme for investors.
